Deutsche Bank
BIOC

Deutsche Bank’s Biocept, Inc. BIOC Stock Holding History

Deutsche Bank’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-80
Closed -$6K – 4984
2019
Q4 		$6K Buy
+80
New +$13.8K ﹤0.01% 4637
2019
Q2 		– Sell
-12
Closed -$4K – 5589
2019
Q1 		$4K Buy
+12
New +$4.86K ﹤0.01% 5047
2018
Q4 		– Hold
0
– – – 5506
2018
Q3 		– Hold
0
– – – 5616
2017
Q3 		– Hold
0
– -$4K – 5163
2017
Q2 		– Hold
0
– – – 4787
2017
Q1 		– Hold
0
– – – 4841

Other funds holding BIOC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank's BIOC Position: Q1 2020 in Review

Deutsche Bank sold out of Biocept, Inc. (BIOC) in Q1 2020, closing a stake of 80 shares — an estimated $6K sold.

Deutsche Bank first reported a position in BIOC in Q1 2019 and held it in 2 quarters. The position peaked at $6K in Q4 2019. 19 funds tracked by Wall St. Rank hold BIOC as of Q1 2020.

  • Deutsche Bank reported no remaining Biocept, Inc. position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 80 Biocept, Inc. shares in Q1 2020, an estimated $6K.
  • Deutsche Bank first reported a position in Biocept, Inc. in Q1 2019 and held it in 2 quarters.
  • Deutsche Bank's Biocept, Inc. position peaked at $6K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Biocept, Inc. as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.